[1] 罗鸿斌,林建华. mTOR信号通路与肿瘤靶向治疗研究进展[J].内蒙古中医药, 2013,32(6):139-140. [2] Avaniyapuram KM,Arasambattu KM,Nobuo T. Genetic deregulation of the PIK3CA oncogene in oral cancer [J]. Cancer Letters,2013,338:193-203. [3] Cully M,You H,Levine AJ,et al. Beyound PTEN mutations:the PI3K pathway as an integrator of multiple inputs during tumorigenesis [J]. Nat Rev Cancer,2006,6(3):184-192. [4] Won HS,Jung CK,Chun SH,et al. Difference in expression of EGFR, pAkt,and PTEN between oropharyngeal and oral cavity squamous cell carcinoma [J]. Oral Oncol,2012,48(10):985-990. [5] Sauk JJ,Nikitakis NG,Scheper MA. Are we on the brink of nonsurgical treatment for ameloblastoma? [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2010,110(1):68-78. [6] Rosen N,She QB. AKT and cancer-is it all mTOR? [J].Cancer Cell,2006, 10(4):254-256. [7] Zhi HC,Li Y,Yong L,et al. LY294002 and rapamycin promote coxsackievirus -induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway [J]. Mol Cell Biochem,2014,385:169-177. [8] Urano J,Sato T,Matsuo T,et al. Point mutations in TOR confer Rheb-independent mammalian TOR signaling in mammalian cells [J]. Proc Natl Acad Sci USA,2007,104(9):3514-3519. [9] Yang H,Wang X,ZHang Y,et al. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity [J].J Cell Physiol,2014,229:17-26. [10] Chen P,Yan H,Chen Y,et al. The variation of AkT/TSC1-TSC1/ mTOR signal pathway in hepatocytes after partial hepatectomy in rats [J]. Exp Mol Pathol ,2009,86(2):101-107. [11] Peng XD,Xu PZ,Chen ML,et al. Dwarfism,impaired skin development, skeletal muscle atrophy,delayed bone development,and impeded adipogenesis in mice lacking Akt1 and Akt2 [J]. Genes Dev,2003,17(11):1352-1365. [12] Radimerski T,Montagne J,Rintelen F,et al. dS6K-regulated cell growth is dPKB/ dPI(3)K-independent, but requires dPDK1 [J]. Nat Cell Biol,2002,4(3):251-255. [13] Gao X,Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth [J]. Genes Dev,2001,15(11):1383-1392. [14] Lyu D,Yu W,Tang N,et al. The mTOR signaling pathway regulates pain-related synaptic plasticity in rat entorhinal-hippocampal pathways [J]. Mol Pain,2013,9:64. [15] Asnaghi L,Bruno P,Priulla M,et al. mTOR:a protein kinase switching between life and death [J]. Pharmacol Res,2004,50(6):545-549. [16] Osyczka AM,Leboy PS. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling [J]. Endocrinology,2005,146:3428-3437. [17] Mukherjee A,Wilson EM,Rotwein P. Selective signaling by Akt2 promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway [J]. Mol Cell Biol,2010,30(4):1018-1027. [18] Lee KW,Yook JY,Son MY,et al. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by clocking the mTOR pathway and stimulating the BMP/Smad pathway [J]. Stem Cell Dev,2010,19(4):557-568. [19] Ogawa T,Tokuda M,Tomizawa K,et al. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma(ROS17/2.8) cells [J]. Biochem Biophys Res Commun,1998,249:226-230. [20] Viñals F,López-Rovira T,Rosa JL,et al. Inhibition of PI3K/p70S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2 [J]. FEBS Lett,2002,510: 99-104. [21] Mandal CC,Ghosh CG,Ghosh-Choudhury N. Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-Induced colony stimulating factor-1(CSF-1)expression and osteoclast differentiation [J]. Endocrinology,2009,150(11):4989-4998. [22] Shoba LNN,Lee JC. Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells [J]. J Cell Biochem,2003,88:1247-1255. [23] 刘奕,孙素芬. 正畸力作用下兔牙周组织中PI3K的表达[J].口腔医学研究,2011,27(2):141-144. [24] 刘奕,孙素芬,孙丽艳. 蛋白激酶B参与正畸牙周组织改建作用实验研究[J]. 中国实用口腔科杂志,2010,3(9):543-544. [25] 郭亚峰,刘奕. 兔牙移动过程中牙周组织核糖体蛋白S6激酶mRNA的表达[J]. 口腔医学,2008,28(9):461-463. [26] Gao N, Flynn DC, Zhang Z,et al. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells [J].Am J Physiol Cell Physiol,2004,287:C281-C291 [27] Molinolo A,Hewitt SM,Amornphimoltham P,et al. Dissecting the Akt/mammalian target of rapamycin signaling network:emerging results from the head and neck cancer tissue array initiative [J]. Clin Cancer Res,2007,13(17):4964-4973. [28] Thomas G. The S6 kinase signaling pathway in the control of development and growth [J]. Biol Res,2002,35(2):305-313. [29] Ihle NT,Powis G. Take your PIK:phosphatidylinositol 3-kinase inhibitor race through the clinic and toward cancer therapy [J]. Mol Cancer Ther,2009,8(1):1-9. [30] Foukas LC,Claret M,Pearce W,et al. Critical role for the p110 alpha phosphoinositide-3-OH kinase in growth and metabolic regulation [J]. Nature,2006,441(7091):366-370. [31] Liu Y,Hidayat S,Su WH,et al. Expression and activity of mTOR and its substrates in different cell cycle phases and in oral squamous cell carcinomas of different malignant grade [J].Cell Biochem Funct,2007,25(1):45-53. [32] Suzuki S,Dobashi Y,Minato H,et al. EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas [J]. Virchows Arch,2012,461(3):271-282. [33] Clauditz TS,Gontarewicz A,Bokemeyer C,et al. Abundant expression of mTOR kinase in salivary gland tumors - potentials as therapy target? [ J]. J Oral Pathol Med,2013,25. [34] 傅锦业,高静. 口腔癌相关危险因素的流行病学调查分析[J]. 中国口腔颌面外科杂志,2011,9(4):316-322. [35] Yin CY,Zhang GY,Yuan X,et al. Effects of cyclic tensile stress on human periodontal ligament fibroblasts apoptosis [J]. Prog in Modern Biomed,2012,12:2847-2851. [36] Wang J,Cao Y,Luo XJ,et al. PI3K-Akt signaling pathway plays protective effects on nicotine induced PDLFs apoptosis [J]. J Environment Health,2012,29(1):42-45. [37] Shimabukuro Y,Terashima H,Takedachi M,et al. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction [J]. J Cell Physiol,2011,226(3): 809-821. 2014-03-20 收稿 2014-09-01 修回 本文编辑:朱冰梅 |